112 related articles for article (PubMed ID: 7295098)
21. [Clinical and metabolic consequences of uremic toxicity].
Rutkowski P
Przegl Lek; 2006; 63(4):209-17. PubMed ID: 17080744
[TBL] [Abstract][Full Text] [Related]
22. The search for the uremic toxin: the case for carbamoylation of amino acids and proteins.
Kraus LM; Kraus AP
Wien Klin Wochenschr; 1998 Aug; 110(15):521-30. PubMed ID: 9782570
[TBL] [Abstract][Full Text] [Related]
23. Characterization of middle molecule compounds.
Zimmerman L; Jörnvall H; Bergström J; Fürst P; Sjövall J
Artif Organs; 1981; 4 Suppl():33-6. PubMed ID: 7295092
[TBL] [Abstract][Full Text] [Related]
24. Effects of ethanol and diphenyl diselenide exposure on the activity of delta-aminolevulinate dehydratase from mouse liver and brain.
Fachinetto R; Pivetta LA; Farina M; Pereira RP; Nogueira CW; Rocha JB
Food Chem Toxicol; 2006 Apr; 44(4):588-94. PubMed ID: 16364531
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate.
Ringoir SM; van Landschoot N; de Smet R
Clin Nephrol; 1980 Mar; 13(3):109-12. PubMed ID: 7379359
[TBL] [Abstract][Full Text] [Related]
26. Rheological properties of red blood cells (including reticulocytes) in patients with chronic renal disease.
Nowak E; Wyrwicz G; Dabrowski Z; Smoleńiski O; Spodaryk K
Clin Hemorheol Microcirc; 1999; 21(2):87-94. PubMed ID: 10599591
[TBL] [Abstract][Full Text] [Related]
27. Some aspects of middle molecules toxicity.
Rinaudo JB; Bernard P; Crest M; Moret JM; Murisasco A; Saingra S; Frayssinet R; Crevat A; Gallice P; Fournier N; Sicardi F
Artif Organs; 1981; 4 Suppl():90-3. PubMed ID: 7295102
[TBL] [Abstract][Full Text] [Related]
28. Glutathione peroxidase, thioredoxin, and membrane protein changes in erythrocytes predict ribavirin-induced anemia.
Grattagliano I; Russmann S; Palmieri VO; Portincasa P; Palasciano G; Lauterburg BH
Clin Pharmacol Ther; 2005 Oct; 78(4):422-32. PubMed ID: 16198661
[TBL] [Abstract][Full Text] [Related]
29. Effect of hypoxia and uremia on oxidative stress on erythrocytes from hemodialysis patients.
Dias GF; Tozoni SS; Bohnen G; van Spitzenbergen BAK; Grobe N; Nakao LS; Pecoits-Filho R; Kotanko P; Moreno-Amaral AN
Cell Biochem Funct; 2022 Dec; 40(8):856-864. PubMed ID: 36121199
[TBL] [Abstract][Full Text] [Related]
30. Human erythrocyte hemolysis induced by selenium and tellurium compounds increased by GSH or glucose: a possible involvement of reactive oxygen species.
Schiar VP; Dos Santos DB; Paixão MW; Nogueira CW; Rocha JB; Zeni G
Chem Biol Interact; 2009 Jan; 177(1):28-33. PubMed ID: 18983990
[TBL] [Abstract][Full Text] [Related]
31. 1,1,2-Tris-organoselenide alkene derivatives, but not 1,2-bis-organoselenide alkene derivatives, inhibited delta-aminolevulinate dehydratase activity from human erythrocytic cells in vitro.
Borges VC; Dadalt G; Savegnago L; Moro AV; Rocha JB; Nogueira CW
Toxicol In Vitro; 2007 Apr; 21(3):387-91. PubMed ID: 17084061
[TBL] [Abstract][Full Text] [Related]
32. Erythrocyte transport of middle molecular substances.
Gajdos M; Spustová V; Geryková M; Dzúrik R
Proc Eur Dial Transplant Assoc; 1981; 18():183-7. PubMed ID: 7329966
[TBL] [Abstract][Full Text] [Related]
33. Immune dysfunction in uremia.
Cohen G; Haag-Weber M; Hörl WH
Kidney Int Suppl; 1997 Nov; 62():S79-82. PubMed ID: 9350688
[TBL] [Abstract][Full Text] [Related]
34. An overview of clinical implications of middle molecules and their kinetics in uremia.
Funck-Brentano JL; Man NK
Artif Organs; 1981; 4 Suppl():125-32. PubMed ID: 7295078
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of CFU-E colony formation in uremic patients with inflammatory disease: role of IFN-gamma and TNF-alpha.
Allen DA; Breen C; Yaqoob MM; Macdougall IC
J Investig Med; 1999 May; 47(5):204-11. PubMed ID: 10361379
[TBL] [Abstract][Full Text] [Related]
36. Mass spectrometry in the search for uremic toxins.
Niwa T
Mass Spectrom Rev; 1997; 16(6):307-32. PubMed ID: 9703693
[TBL] [Abstract][Full Text] [Related]
37. Long-term erythropoietin therapy does not affect endothelial markers, coagulation activation and oxidative stress in haemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2007; 120(6):797-803. PubMed ID: 17391740
[TBL] [Abstract][Full Text] [Related]
38. Direct inhibitory effect of uremic toxins and polyamines on proliferation of VERO culture cells.
Stabellini G; Mariani G; Pezzetti F; Calastrini C
Exp Mol Pathol; 1997; 64(3):147-55. PubMed ID: 9439480
[TBL] [Abstract][Full Text] [Related]
39. Uremic toxicity and anemia.
Bonomini M; Sirolli V
J Nephrol; 2003; 16(1):21-8. PubMed ID: 12649531
[TBL] [Abstract][Full Text] [Related]
40. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
Alhamdani MS
Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
